Sequoia Financial Advisors LLC Acquires 1,556 Shares of Cardinal Health, Inc. (NYSE:CAH)

Sequoia Financial Advisors LLC grew its holdings in Cardinal Health, Inc. (NYSE:CAH) by 41.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,330 shares of the company’s stock after acquiring an additional 1,556 shares during the period. Sequoia Financial Advisors LLC’s holdings in Cardinal Health were worth $537,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of CAH. RFG Advisory LLC bought a new position in shares of Cardinal Health during the 4th quarter valued at approximately $332,000. International Assets Investment Management LLC bought a new position in shares of Cardinal Health in the fourth quarter worth approximately $37,393,000. Bleakley Financial Group LLC increased its stake in shares of Cardinal Health by 10.2% in the fourth quarter. Bleakley Financial Group LLC now owns 4,276 shares of the company’s stock worth $431,000 after purchasing an additional 395 shares in the last quarter. Equitable Trust Co. raised its position in shares of Cardinal Health by 7.1% during the 4th quarter. Equitable Trust Co. now owns 4,206 shares of the company’s stock valued at $424,000 after purchasing an additional 277 shares during the period. Finally, Wakefield Asset Management LLLP lifted its stake in shares of Cardinal Health by 565.6% during the 4th quarter. Wakefield Asset Management LLLP now owns 32,021 shares of the company’s stock valued at $3,229,000 after buying an additional 27,210 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.1 %

NYSE:CAH opened at $107.19 on Wednesday. The company has a market cap of $26.07 billion, a price-to-earnings ratio of 42.20, a price-to-earnings-growth ratio of 1.01 and a beta of 0.68. Cardinal Health, Inc. has a twelve month low of $77.56 and a twelve month high of $116.04. The stock has a fifty day simple moving average of $109.45 and a 200-day simple moving average of $104.00.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, February 1st. The company reported $1.82 earnings per share for the quarter, beating analysts’ consensus estimates of $1.56 by $0.26. The company had revenue of $57.45 billion during the quarter, compared to analyst estimates of $57.02 billion. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter last year, the business posted $1.32 EPS. As a group, equities research analysts predict that Cardinal Health, Inc. will post 7.28 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were paid a $0.5006 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.87%. The ex-dividend date was Thursday, March 28th. Cardinal Health’s dividend payout ratio (DPR) is presently 78.74%.

Analysts Set New Price Targets

CAH has been the topic of several recent analyst reports. TheStreet downgraded Cardinal Health from a “b-” rating to a “c+” rating in a research note on Wednesday, December 27th. SVB Leerink assumed coverage on shares of Cardinal Health in a report on Monday, February 26th. They issued an “outperform” rating and a $125.00 target price on the stock. Leerink Partnrs reaffirmed an “outperform” rating on shares of Cardinal Health in a research note on Monday, February 26th. Barclays initiated coverage on shares of Cardinal Health in a report on Wednesday, January 3rd. They issued an “overweight” rating and a $117.00 price target on the stock. Finally, Argus raised shares of Cardinal Health from a “hold” rating to a “buy” rating in a report on Friday, February 9th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $103.07.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.